RobertFenstermakerMDFACS, FAANS
Neurosurgery • Buffalo, NYBrain & Spinal Tumor, Pituitary Surgery, Skull Base, Stereotactic & Functional Neurosurgery
Professor of Neurological Surgery and Oncology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo and Roswell Park Comprehensive Cancer Center
Dr. Fenstermaker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton St
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-8980
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurological Surgery, 1988 - 1989- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurological Surgery, 1982 - 1987
- Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Transitional Year, 1981 - 1982
Northeast Ohio Medical UniversityClass of 1981
Certifications & Licensure
NY State Medical License 1994 - 2026
OH State Medical License 1986 - 2007- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2022
- Buffalo Spree Magazine Castle Connolly, 2006, 2008, 2010-2016
- America's Top Doctors for Cancer Castle Connolly, 2011-2013
- Join now to see all
Clinical Trials
- Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma Start of enrollment: 2012 Sep 05
- SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2015 May 04
- Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac® Start of enrollment: 2023 Apr 11
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- 37 citationsPhase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma.Manmeet S Ahluwalia, David A Reardon, Ajay P Abad, William T Curry, Eric T Wong
Journal of Clinical Oncology. 2023-03-01 - 108 citationsClinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant gliomaRobert A. Fenstermaker, Michael J. Ciesielski, Jingxin Qiu, Nuo Yang, Cheryl Frank
Cancer Immunology, Immunotherapy. 2016-08-30 - 16 citationsProspective prediction of clinical drug response in high-grade gliomas using an ex vivo 3D cell culture assayStephen Shuford, Lindsay Lipinski, Ajay Abad, Ashley M. Smith, Melissa Rayner
Neuro-Oncology Advances. 2021-01-01
Journal Articles
- Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed GlioblastomaManmeet S Ahluwalia, David A Reardon, Ajay P Abad, William T Curry, Eric T Wong, Sheila A Figel, Laszlo L Mechtler, David M Peereboom, Alan D Hutson, Henry G Withers, ..., J Clin Oncol, 12/15/2022
Press Mentions
Castle Connolly Names 38 Roswell Park Physicians to ‘Top Doctors’ ListFebruary 2nd, 2023- Roswell Park Oncology Experts Named to Castle Connolly ‘Top Doctors’ ListAugust 4th, 2022
- Roswell Park-Developed Immunotherapy Now Part of Nationwide Study in Kids with Brain CancerJune 7th, 2022
- Join now to see all
Professional Memberships
- Member
- Fellow
- Member
Industry Relationships
- co-Founder and Chief Medical Officer, MimiVax, LLCMimiVax, LLC is a biotechnology company focused on immuno-oncology2012 - 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
